Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial - Wykoff, C C; Brown, D M; Reed, K (JAMA Ophthalmol, 2023)